ClinicalTrials.govcontrolled
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).
ClinicalTrials.gov study NCT05011513. IPD Sharing: YES. Countries: 20. Publications: 3.
ShareScore
36/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 12
- Harmonization
- 12
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8